期刊文献+

口服不同剂型替米考星在鸡体内相对生物等效性研究 被引量:6

Relative bioequivalence of tilmicosin(powder or liquid) oral formulations in chickens
下载PDF
导出
摘要 本试验按单剂量口服的方法对健康蛋鸡进行替米考星可溶性粉和替米考星溶液中主要组分替米考星的生物利用度和药代动力学研究。利用HPLC方法分析不同时间点试验鸡血浆中的药物浓度。药物的药动学参数结果显示,替米考星可溶性粉和替米考星溶液的平均血药浓度-时间曲线下面积(AUC0-48)分别为(16.947±0.624)μg/mL.h和(16.020±0.631)μg/mL.h,没有显著差异;二者AUC0-48比值为1.058,Cmax分别为(0.759±0.012)μg/mL和(0.764±0.012)μg/mL,比值为0.993;替米考星可溶性粉和替米考星溶液的t1/2β、C l(s)、t1/2 Ka和V/F(c)均没有显著差异;二者的tmax分别为(1.211±0.036)h和(1.030±0.063)h虽然有显著差异,但并不能以此说明二者生物学的非等效性。试验结果说明,单剂量口服替米考星可溶性粉和替米考星溶液后,替米考星被迅速吸收,消退缓慢,依据生物等效性的重要评判指标,得出替米考星可溶性粉和替米考星溶液在治疗中可以相互替代。 The bioavailability and pharmacokinetics of tilmicosin were investigated in the healthy chickens given a single oral dose of the soluble powder or the liquid of tilmicosin. A modified rapid and sensitive HPLC method was used for determination of tilmicosin concentra- tions in the tested chicken plasma. Various pharmacokinetic parameters including area under plasma concentration-time curve ( AUC0-48), maximum plasma concentration (Cmax), time to peak concentration (tmax), elimination half-life (t1/2β) , body clearance (Cl), absorption half-life ( t1/2 Ka) and coefficient of volume of distribution/absorption (V/F) were determined for both administrations, respectively. The average means of AUC0-48 for the soluble powder ( 16. 947±0. 624) g/mL·h and the liquid ( 16. 020±0. 631 ) g/mL·h were very close, with-out a significant difference based on ANOVA. The relative bioavailability of tilmicosin powder was 106% compared to the tilmicosin liquid. There were no significant differences in the Cmax, t1/2β, Cl (s), t1/2 Ka and V/F (c) between the soluble powder and the liquid of tilmicosin. In addition, there exists a significant difference in tmax between the soluble powder ( 1. 211±0. 036) h and the liquid ( 1. 030±0. 063) h, but this difference couldn't deny the relative bioequivalence of the two preparations. Tilmicosin could be rapidly absorbed and slowly elim- inated after a single dose of oral administration in whether aqueous or its soluble powder formulations. It suggested that the two formulations Of Tilmicosin could be used interchangeably in drug therapy.
出处 《畜牧与兽医》 北大核心 2009年第4期14-18,共5页 Animal Husbandry & Veterinary Medicine
关键词 生物利用度 HPLC 替米考星 药动学 bioavailability chicken HPLC tilmicosin pharmacokinetics
  • 相关文献

参考文献12

  • 1梁文权.生物药剂学与药物动力学[M].2版.北京:人民卫生出版社,2004:222-224.
  • 2江海洋,沈建忠,胡顶飞.兽用抗菌药物替米考星[J].中国兽药杂志,2002,36(8):28-31. 被引量:46
  • 3李宏胜,张继瑜,周旭正,李建勇,李金善,苗小楼,许忠赞,张占峰.替米考星注射剂治疗人工感染猪传染性胸膜肺炎的效果观察[J].中国兽药杂志,2008,42(7):26-29. 被引量:12
  • 4Gokhan E. Effects of different doses of tilmicosin on erythrocyte catalase activity and plasma malondialdehyde levels in chicks [ J]. Bull Vet Inst Pulawy, 2007, 51 : 145-147.
  • 5Scomeaux B, Shrycok T R. Intracelluar accumulation, subcellular distribution, and efflux of tilmicosin in chicken phagocytes [ J ]. Poult Sci, 1998, 77(10) : 1510-1521.
  • 6Scomeaux B, Shrycok T R. Intracelluar accumulation, subcellular distribution, and efflux of tilmicosin in bovine mammary, blood, and lung cells [J]. J Dairy Sci, 1999, 82(6) : 1202-1212.
  • 7Abu-Bashal E A, Idkaidek N M, Al-Shunnaq A F. Phannacokinetics of tilmicosin ( Provitil powder and Pulmotil liquid AC) oral formulations in chickens [ J ]. Veterinary Research Communications, 2007, 31(4): 477-485.
  • 8Keles O, Bakirel T, Sener S. Pharmacokinetics and tissue levels of tilmicosin in fowls [J]. Turk J Vet Anim Sci, 2001, 25(4) : 629- 634.
  • 9Dergham A, Ehab A, Rana R. Control of mycoplasma gallisepticum infection in commercial broiler breeder chicken flocks using tilmicosin ( Provitil Powder ) oral formulation[J].International Journal of Poultry Science, 2006, 5 (10) : 949-954.
  • 10Chen Mei-Ling, Vinod Shah, Rabindra Patnaik, et al. Bioavailability and bioequivalence : an FDA regulatory overview [ J ]. Pharmaceutical Research, 2001, 18(12): 1645-1650.

二级参考文献49

  • 1KoenChiers,唐文渊,梁润泽.传染性胸膜肺炎的防制[J].国外畜牧学(猪与禽),2004(2):34-35. 被引量:5
  • 2刘秀玲.中西药结合治疗猪传染性胸膜炎[J].中兽医学杂志,2006(2):20-21. 被引量:8
  • 3陈华美,肖国生,文心田.猪胸膜肺炎放线杆菌的血清型分型及毒力因子研究进展[J].中国兽药杂志,2006,40(4):35-40. 被引量:10
  • 4刘霞,刁有祥,禚宝山.猪传染性胸膜肺炎的研究进展[J].山东农业大学学报(自然科学版),2006,37(1):152-156. 被引量:12
  • 5宜长和 任凤兰 孙福先.猪病学[M].北京:中国农业科技出版社,1996..
  • 6Zielinski G C, Piscitelli H G, Perez M H, et al. Efficacy of differentdosage levels and routes of inoculation of tilmicosin in a natural outbreakof infectious bovine keratoconjunctivitis[R]. Proceedings of the Thirty-Second Annual Conference American Association of Bovine Practitioners,1999.261.
  • 7Gokce G, Sahin M, Genc O, et al. Comparative studies on the efficacyof tilmicosin and danofloxacin in treating calf pneumonia [J]. KafkasUniversitesi Veteriner Fakultesi Dergisi, 1997, 3(2):151-155.
  • 8Kempf I, Reeve J L, Gesbert F, et al. Efficacy of tilmicosin in the controlof experimental Mycoplasma gallisepticum infection in chickens [J].Avian Diseases, 1997, 41(4):802-807.
  • 9Nickerson S C, Owens W E, Fox L K, et al. Comparison of tilmicosinand cephapirin as therapeutics for Staphylococus aureus mastitis atdry-off [J]. Journal of Dairy Science, 1999, 82(4):696-703.
  • 10Croft A, Duffield T, Menzies P, et al. The effect of tilmicosin administeredto ewes prior to lambing on incidence of clinical mastitis and subsequentlamb performance[J]. Canadian Veterinary Journal, 2000, 41(4):306-311.

共引文献58

同被引文献51

引证文献6

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部